<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>APPROVED</status><version>v2</version><patient-age>62</patient-age><report-id>PHHY2012GB113686</report-id><gender>male</gender><reactions><reaction>Small bowel obstruction</reaction><reaction>Left upper quadrant pain</reaction><reaction>Vomiting</reaction><reaction>Increasing abdominal tenderness and distension</reaction><reaction>Resected specimen showed areas of oedema and ulceration</reaction><reaction>Transmural necrosis with quite extensive fibrosis</reaction><reaction>Histological review of a resected specimen showed haemorrhage and severe ulceration.</reaction><reaction>Lower abdominal pain</reaction><reaction>Cancer was progressed/Small cell lung cancer</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>ETOPOSIDE </drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CARBOPLATIN </drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ETOPOSIDE</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Small cell lung cancer stage unspecified</indication></indications><patient-age>62</patient-age><outcomes/><country>United Kingdom</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4053445_286</messagenumb>
		<messagesenderidentifier>NovartisGX</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20121211155601</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>1</safetyreportversion>
		<safetyreportid>PHHY2012GB113686</safetyreportid>
		<primarysourcecountry>GB</primarysourcecountry>
		<occurcountry>GB</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2012-12-11</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2012-11-09</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2012-11-09</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHHY2012GB113686</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reportergivename>Jig</reportergivename>
			<reporterfamilyname>Coward</reporterfamilyname>
			<reportercountry>GB</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
			<literaturereference>Coward JIG, Ding N-L, Feakins R, Kocher H, Popat S, Szlosarek PW. Chemotherapy-induced bowel obstruction in small cell lung cancer: A case report. Medical Oncology. 2012;29 (4):2623-2625</literaturereference>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>SANDOZ,Inc.</senderorganization>
			<senderdepartment>DS&amp;E</senderdepartment>
			<senderstreetaddress>Sandoz Inc., Broomfield Site 2555 West Midway Boulevard</senderstreetaddress>
			<sendercity>Broomfield</sendercity>
			<senderstate>Colorado</senderstate>
			<senderpostcode>80038</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>800525</sendertel>
			<sendertelextension>2492</sendertelextension>
			<sendertelcountrycode>1</sendertelcountrycode>
			<senderfax>7208873940</senderfax>
			<senderfaxextension>4870</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>--</patientinitial>
			<patientonsetage>62</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientsex code="1">Male</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Small cell lung cancer stage unspecified</patientepisodename>
				<patientmedicalstartdateformat>610</patientmedicalstartdateformat>
				<patientmedicalstartdate>200512</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Laparotomy</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Small intestinal resection</patientepisodename>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Small bowel obstruction</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Small bowel obstruction</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Small intestinal obstruction</reactionmeddrapt>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Left upper quadrant pain</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Left upper quadrant pain</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Abdominal pain upper</reactionmeddrapt>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Vomiting</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Vomiting</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Vomiting</reactionmeddrapt>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Increasing abdominal tenderness and distension</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Abdominal tenderness</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Abdominal tenderness</reactionmeddrapt>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Increasing abdominal tenderness and distension</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Abdominal distension gaseous</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Abdominal distension</reactionmeddrapt>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Resected specimen showed areas of oedema and ulceration</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Ulceration of intestine</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Intestinal ulcer</reactionmeddrapt>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Resected specimen showed areas of oedema and ulceration</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Intestinal oedema</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Gastrointestinal oedema</reactionmeddrapt>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Transmural necrosis with quite extensive fibrosis</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Small intestinal necrosis</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Gastrointestinal necrosis</reactionmeddrapt>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Histological review of a resected specimen showed haemorrhage and severe ulceration.</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Small intestinal ulcer haemorrhage</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Small intestinal ulcer haemorrhage</reactionmeddrapt>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Lower abdominal pain</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Lower abdominal pain</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Abdominal pain lower</reactionmeddrapt>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Cancer was progressed/Small cell lung cancer</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Small cell lung cancer</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Small cell lung cancer stage unspecified</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<test>
				<testname>Abdominal X-ray</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testname>Computerised tomogram</testname>
				<moreinformation>1</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>ETOPOSIDE </medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugstructuredosagenumb>200</drugstructuredosagenumb>
				<drugstructuredosageunit code="009"/>
				<drugdosagetext>200 mg/m2, on day 1</drugdosagetext>
				<drugadministrationroute code="042">Intravenous (not otherwise specified)</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Small cell lung cancer stage unspecified</drugindication>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>ETOPOSIDE</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal distension</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal distension</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain lower</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain lower</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain upper</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain upper</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal tenderness</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal tenderness</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal necrosis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal necrosis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal oedema</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal oedema</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Intestinal ulcer</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Intestinal ulcer</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Small cell lung cancer stage unspecified</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Small cell lung cancer stage unspecified</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Small intestinal obstruction</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Small intestinal obstruction</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Small intestinal ulcer haemorrhage</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Small intestinal ulcer haemorrhage</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Vomiting</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Vomiting</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>CARBOPLATIN </medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationnumb>76-959</drugauthorizationnumb>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: Generics</drugauthorizationholder>
				<drugadministrationroute code="042">Intravenous (not otherwise specified)</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Small cell lung cancer stage unspecified</drugindication>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CARBOPLATIN</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal distension</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal distension</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain lower</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain lower</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain upper</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain upper</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal tenderness</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal tenderness</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal necrosis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal necrosis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal oedema</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal oedema</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Intestinal ulcer</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Intestinal ulcer</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Small cell lung cancer stage unspecified</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Small cell lung cancer stage unspecified</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Small intestinal obstruction</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Small intestinal obstruction</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Small intestinal ulcer haemorrhage</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Small intestinal ulcer haemorrhage</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Vomiting</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Vomiting</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>ETOPOSIDE</medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugstructuredosagenumb>100</drugstructuredosagenumb>
				<drugstructuredosageunit code="009"/>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>100 mg/m2, BID</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Small cell lung cancer stage unspecified</drugindication>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>ETOPOSIDE</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>Case number PHHY2012GB113686 is an <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">initial </Semaphore>literature report received on 09 Dec 2012. In this article, the author discussed about a case report of <Semaphore x="1760803" class="Procedure" value="Chemotherapy" score="1.00" ID="C15632">chemotherapy </Semaphore>induced <Semaphore x="1623372" class="Disease or Finding" value="Bowel Obstruction" score="1.00" ID="C9175">bowel obstruction </Semaphore>in a patient with <Semaphore x="2530039" class="Disease or Finding" value="Small Cell Carcinoma" score="1.00" ID="C3915">small cell <Semaphore x="2133397" class="AnatomicStructure" value="Lung" score="1.00" ID="C12468">lung </Semaphore>cancer </Semaphore>(<Semaphore x="2530039" class="Disease or Finding" value="Small Cell Carcinoma" score="1.00" ID="C3915">SCLC</Semaphore>). This case refers to a 62-year old male patient <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed </Semaphore>with <Semaphore x="2530039" class="Disease or Finding" value="Small Cell Carcinoma" score="1.00" ID="C3915">SCLC </Semaphore>in Dec 2005. The patient was receiving <Semaphore x="1760803" class="Procedure" value="Chemotherapy" score="1.00" ID="C15632">chemotherapy </Semaphore>for <Semaphore x="2530039" class="Disease or Finding" value="Small Cell Carcinoma" score="1.00" ID="C3915">SCLC</Semaphore>, which comprised IV <Semaphore x="305407" class="Medicine" value="Carboplatin" score="0.87" ID="266980">carboplatin </Semaphore>AUC 5 (manufacturer/dosage unknown) on day 1, IV <Semaphore x="555467" class="Medicine" value="Etoposide" score="0.93" ID="268016">etoposide </Semaphore>(<Semaphore x="2199623" class="Occupation" value="Manufacturer" score="1.00" ID="C25392">manufacturer </Semaphore>unknown) 200 mg/m^2 on day 1 and <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore><Semaphore x="555467" class="Medicine" value="Etoposide" score="0.93" ID="268016">etoposide </Semaphore>100 mg/m^2, BID on days 2 and 3. He developed <Semaphore x="1409722" class="Disease or Finding" value="Abscess Leakage" score="1.00" ID="C40418">sudden </Semaphore>onset of <Semaphore x="2706678" class="MedDRA LLT" value="Abdominal pain upper" score="1.00" ID="10000087">left upper quadrant <Semaphore x="2365183" class="Disease or Finding" value="Pain" score="1.00" ID="C3303">pain </Semaphore></Semaphore>associated with <Semaphore x="2693861" class="Disease or Finding" value="Vomiting" score="1.00" ID="C3442">vomiting </Semaphore>on day 8. An <Semaphore x="1405836" class="Procedure" value="Abdominal Radiography" score="1.00" ID="C38102">abdominal x ray </Semaphore>showed faecal loading in his <Semaphore x="1548595" class="AnatomicStructure" value="Ascending Colon" score="1.00" ID="C12265">ascending colon </Semaphore>and <Semaphore x="2954820" class="MedDRA LLT" value="Flatulence" score="1.00" ID="10016766">gas </Semaphore>in his rectosigmoid and proximal <Semaphore x="2068925" class="Procedure" value="Intestine Resection" score="1.00" ID="C51652">bowel </Semaphore>loop. His symptoms settled initially with <Semaphore x="2365045" class="Procedure" value="Pain Therapy" score="1.00" ID="C15180">analgesia</Semaphore>. However, after a further week, he developed increasing <Semaphore x="1405486" class="Disease or Finding" value="Abdominal Distention" score="1.00" ID="C78161"><Semaphore x="2707172" class="MedDRA LLT" value="Abdominal tenderness" score="1.00" ID="10000097">abdominal <Semaphore x="2605134" class="Disease or Finding" value="Tenderness" score="1.00" ID="C75540">tenderness </Semaphore></Semaphore>and <Semaphore x="2706105" class="MedDRA LLT" value="Abdominal distension" score="1.00" ID="10000060">distension</Semaphore></Semaphore>. An <Semaphore x="2443785" class="Procedure" value="Radiography" score="1.00" ID="C38101">x ray </Semaphore>and <Semaphore x="2871950" class="MedDRA LLT" value="Computerised tomogram" score="1.00" ID="10010234">CT <Semaphore x="2444079" class="Procedure" value="Radionuclide Imaging" score="1.00" ID="C62667">scan </Semaphore></Semaphore>showed <Semaphore x="3253328" class="MedDRA LLT" value="Small intestinal obstruction" score="1.00" ID="10041101"><Semaphore x="2534994" class="AnatomicStructure" value="Small Intestine" score="1.00" ID="C12386"><Semaphore x="2534830" class="Disease or Finding" value="Small Intestine Cancer TNM Finding v7" score="1.00" ID="C89862"><Semaphore x="2534724" class="Disease or Finding" value="Small Intestine Cancer pTX TNM Finding v7" score="1.00" ID="C89865"><Semaphore x="2534618" class="Disease or Finding" value="Small Intestine Cancer pTis TNM Finding v7" score="1.00" ID="C89867"><Semaphore x="2534512" class="Disease or Finding" value="Small Intestine Cancer pT4 TNM Finding v7" score="1.00" ID="C89873"><Semaphore x="2534406" class="Disease or Finding" value="Small Intestine Cancer pT3 TNM Finding v7" score="1.00" ID="C89872"><Semaphore x="2534300" class="Disease or Finding" value="Small Intestine Cancer pT2 TNM Finding v7" score="1.00" ID="C89871"><Semaphore x="2534194" class="Disease or Finding" value="Small Intestine Cancer pT1b TNM Finding v7" score="1.00" ID="C89870"><Semaphore x="2534088" class="Disease or Finding" value="Small Intestine Cancer pT1a TNM Finding v7" score="1.00" ID="C89869"><Semaphore x="2533980" class="Disease or Finding" value="Small Intestine Cancer pT1 TNM Finding v7" score="1.00" ID="C89868"><Semaphore x="2533874" class="Disease or Finding" value="Small Intestine Cancer pT0 TNM Finding v7" score="1.00" ID="C89866"><Semaphore x="2533768" class="Disease or Finding" value="Small Intestine Cancer pNX TNM Finding v7" score="1.00" ID="C89875"><Semaphore x="2533662" class="Disease or Finding" value="Small Intestine Cancer pN2 TNM Finding v7" score="1.00" ID="C89878"><Semaphore x="2533556" class="Disease or Finding" value="Small Intestine Cancer pN1 TNM Finding v7" score="1.00" ID="C89877"><Semaphore x="2533450" class="Disease or Finding" value="Small Intestine Cancer pN0 TNM Finding v7" score="1.00" ID="C89876"><Semaphore x="2533344" class="Disease or Finding" value="Small Intestine Cancer pM1 TNM Finding v7" score="1.00" ID="C89880"><Semaphore x="2533235" class="Disease or Finding" value="Small Intestine Cancer Pathologic TNM Finding v7" score="1.00" ID="C89863"><Semaphore x="2533125" class="Disease or Finding" value="Small Intestine Cancer Pathologic Regional Lymph Nodes TNM Finding v7" score="1.00" ID="C89874"><Semaphore x="2533012" class="Disease or Finding" value="Small Intestine Cancer Pathologic Primary Tumor TNM Finding v7" score="1.00" ID="C89864"><Semaphore x="2532905" class="Disease or Finding" value="Small Intestine Cancer Pathologic Distant Metastasis TNM Finding v7" score="1.00" ID="C89879"><Semaphore x="2532799" class="Disease or Finding" value="Small Intestine Cancer cM1 TNM Finding v7" score="1.00" ID="C89884"><Semaphore x="2532693" class="Disease or Finding" value="Small Intestine Cancer cM0 TNM Finding v7" score="1.00" ID="C89883"><Semaphore x="2532586" class="Disease or Finding" value="Small Intestine Cancer Clinical TNM Finding v7" score="1.00" ID="C89881"><Semaphore x="2532478" class="Disease or Finding" value="Small Intestine Cancer Clinical Distant Metastasis TNM Finding v7" score="1.00" ID="C89882"><Semaphore x="2532170" class="AnatomicStructure" value="Small Intestinal Wall Tissue" score="1.00" ID="C33573"><Semaphore x="2068954" class="AnatomicStructure" value="Intestine" score="1.00" ID="C12736">small <Semaphore x="1623372" class="Disease or Finding" value="Bowel Obstruction" score="1.00" ID="C9175">bowel </Semaphore></Semaphore>
                              <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                               </Semaphore></Semaphore>
                             <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                              </Semaphore></Semaphore>
                            <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                             </Semaphore></Semaphore>
                           <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                            </Semaphore></Semaphore>
                          <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                           </Semaphore></Semaphore>
                         <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                          </Semaphore></Semaphore>
                        <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                         </Semaphore></Semaphore>
                       <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                        </Semaphore></Semaphore>
                      <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                       </Semaphore></Semaphore>
                     <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                      </Semaphore></Semaphore>
                    <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                     </Semaphore></Semaphore>
                   <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                    </Semaphore></Semaphore>
                  <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                   </Semaphore></Semaphore>
                 <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                  </Semaphore></Semaphore>
                <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                 </Semaphore></Semaphore>
               <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
                </Semaphore></Semaphore>
              <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
               </Semaphore></Semaphore>
             <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
              </Semaphore></Semaphore>
            <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
             </Semaphore></Semaphore>
           <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
            </Semaphore></Semaphore>
          <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
           </Semaphore></Semaphore>
         <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
          </Semaphore></Semaphore>
        <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
         </Semaphore></Semaphore>
       <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
        </Semaphore></Semaphore>
      <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
       </Semaphore></Semaphore>
     <Semaphore x="3046307" class="MedDRA LLT" value="Intestinal obstruction" score="1.00" ID="10022687">
      <Semaphore x="1623372" class="Disease or Finding" value="Bowel Obstruction" score="1.00" ID="C9175">obstruction</Semaphore></Semaphore></Semaphore>. The patient underwent <Semaphore x="2093608" class="Procedure" value="Laparotomy" score="1.00" ID="C15266">laparotomy </Semaphore>and <Semaphore x="2068925" class="Procedure" value="Intestine Resection" score="1.00" ID="C51652">bowel resection </Semaphore>which resolved his <Semaphore x="2328669" class="Disease or Finding" value="Obstruction" score="1.00" ID="C3284">obstruction</Semaphore>. Pathological review of a resected <Semaphore x="1594932" class="Procedure" value="Biospecimen Collection" score="1.00" ID="C70945">specimen </Semaphore>showed areas of <Semaphore x="3150169" class="MedDRA LLT" value="Oedema" score="1.00" ID="10030095">oedema </Semaphore>and ulceration. <Semaphore x="2026985" class="Disease or Finding" value="Histologic Chorioamnionitis" score="1.00" ID="C111944">Histological </Semaphore>analysis revealed transmural <Semaphore x="1910610" class="Disease or Finding" value="Extensive Necrosis" score="1.00" ID="C41612"><Semaphore x="3125797" class="MedDRA LLT" value="Necrosis" score="1.00" ID="10028851">necrosis </Semaphore>with quite extensive </Semaphore><Semaphore x="1935378" class="Disease or Finding" value="Fibrosis" score="1.00" ID="C3044">fibrosis </Semaphore>and <Semaphore x="2015671" class="Disease or Finding" value="Hemorrhage" score="1.00" ID="C26791">haemorrhage </Semaphore>and severe ulceration. There were organized thrombi in a few subserosal and submucosal <Semaphore x="1608287" class="AnatomicStructure" value="Blood Vessel" score="1.00" ID="C12679">blood vessels</Semaphore>. He underwent a second cycle of <Semaphore x="305407" class="Medicine" value="Carboplatin" score="0.87" ID="266980">carboplatin </Semaphore>and <Semaphore x="555467" class="Medicine" value="Etoposide" score="0.93" ID="268016">etoposide </Semaphore><Semaphore x="1760803" class="Procedure" value="Chemotherapy" score="1.00" ID="C15632">chemotherapy </Semaphore>in Feb 2006 and experienced <Semaphore x="1409722" class="Disease or Finding" value="Abscess Leakage" score="1.00" ID="C40418">sudden </Semaphore>onset <Semaphore x="2125229" class="Disease or Finding" value="Lower Abdominal Pain" score="1.00" ID="C35272">lower <Semaphore x="2706839" class="MedDRA LLT" value="Abdominal pain" score="1.00" ID="10000081">abdominal pain </Semaphore></Semaphore>associated with <Semaphore x="2693861" class="Disease or Finding" value="Vomiting" score="1.00" ID="C3442">vomiting </Semaphore>on day 3. His <Semaphore x="2707150" class="MedDRA LLT" value="Abdominal symptom" score="1.00" ID="10060926">abdominal symptoms </Semaphore>rapidly deteriorated. An <Semaphore x="2443785" class="Procedure" value="Radiography" score="1.00" ID="C38101">x ray </Semaphore>and <Semaphore x="2871950" class="MedDRA LLT" value="Computerised tomogram" score="1.00" ID="10010234">CT <Semaphore x="2444079" class="Procedure" value="Radionuclide Imaging" score="1.00" ID="C62667">scan </Semaphore></Semaphore>revealed an abdominal purulent <Semaphore x="1791788" class="Procedure" value="Collection of Non-Human Source Plasma" score="1.00" ID="C112935">collection </Semaphore>that was <Semaphore x="1863848" class="Procedure" value="Drainage" score="1.00" ID="C50434">drained </Semaphore>and a dilated <Semaphore x="2068954" class="AnatomicStructure" value="Intestine" score="1.00" ID="C12736">small bowel</Semaphore>. He underwent conservative <Semaphore x="1788170" class="Procedure" value="Clinical Treatment" score="1.00" ID="C15786">treatment and his clinical </Semaphore>state improved. His <Semaphore x="3127610" class="MedDRA LLT" value="Neoplasm malignant" score="1.00" ID="10028997">cancer </Semaphore>had progressed to his <Semaphore x="2614087" class="AnatomicStructure" value="Thorax" score="1.00" ID="C12799">thorax </Semaphore>and he was transferred to a <Semaphore x="2032278" class="Procedure" value="Hospice Care" score="1.00" ID="C15252">hospice</Semaphore>. Second <Semaphore x="2122602" class="AnatomicStructure" value="Long Interspersed Element" score="1.00" ID="C13803">line </Semaphore><Semaphore x="1760803" class="Procedure" value="Chemotherapy" score="1.00" ID="C15632">chemotherapy </Semaphore>was not considered. The author commented that this case report documented the observation of <Semaphore x="1623372" class="Disease or Finding" value="Bowel Obstruction" score="1.00" ID="C9175">bowel obstruction </Semaphore>induced by <Semaphore x="305407" class="Medicine" value="Carboplatin" score="0.87" ID="266980">carboplatin </Semaphore>and <Semaphore x="555467" class="Medicine" value="Etoposide" score="0.93" ID="268016">etoposide</Semaphore>. A full text had been ordered.</narrativeincludeclinical>
				<sendercomment>Serious literature report: Small intestinal obstruction, Intestinal ulcer, Gastrointestinal necrosis [medically significant], assessed as unlisted according to the Core Data Sheet. The information provided in this individual case does not warrant a change to the Core Data Sheet text. The topic will be monitored closely. 

Small intestinal ulcer haemorrhage, Small cell lung cancer stage unspecified [medically significant], already listed in the Core Data Sheet. All literature reports are considered suspected for reporting purposes or in accordance with national regulatory requirements.

MAC: Based on review of available reported data, possibility of causal relationship for the event(s) can’t be ruled out.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>